CANGANY PETER T JR purchased $20K of BENF

CANGANY PETER T JR purchased 18,868 shares of Beneficient (BENF) at $1.06 on 2026-09-15.

Original reporting
SEC EDGAR · CANGANY PETER T JR
Published Sep 17, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BENF
Neutral
medium confidence
Mentioned
$BENF
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BENFNeutralLow
01

Why it matters

The filing provides a first‑report of a modest insider purchase, offering limited actionable insight.

02

Market read

Routine insider purchase with minimal market impact.

03

What to watch

Potential upcoming clinical data or partnership that prompted the insider buy.

Relevance 4/10Novelty 4/10Timing: filed Sep 17 2026

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$BENFNeutralMedium confidence
Context

Director Cangany Peter T Jr bought 18,868 shares of Beneficient at $1.06 each, increasing his stake to 98,529 shares.

Expected impact

Minimal short-term price movement expected.

Evidence & confidence

The $20k purchase is a routine insider transaction for a micro‑cap; while it may slightly support the stock, the amount is too small to drive significant price action.

Market effects

None significant; Beneficient operates in a niche biotech segment with limited sector ripple.

No broader regional effect.

Negligible.

Counterpoint

The purchase could be a signal of upcoming positive news not yet public.

Key entities

  • Beneficient

    Public biotech issuer (ticker BENF).

  • Cangany Peter T Jr

    Director of Beneficient.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles